Ridgepost Capital, Inc.
RPC NYSE Investment Advice Financials FY2019βFY2025
What Ridgepost Capital, Inc. does
No business description yet.
- Legal name
- Ridgepost Capital, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 27, 2026
- Accession Β· CIK
- 0001193125-26-081484
0001841968
Revenue and margins
Ridgepost Capital, Inc. had $297M of revenue in fiscal 2025, up 0.3% on the year before.
Net income and earnings per share
From fiscal 2019 to 2025, diluted EPS grew β1.8% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $18.1M in fiscal 2025, 6.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Ridgepost Capital, Inc. returned $16.3M to shareholders in fiscal 2025, 90% of free cash flow. The diluted share count fell 1.9%.
Balance sheet
Cash, debt and the ratios that show how comfortably Ridgepost Capital, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $40.9M | $20.0M | $30.5M | $67.5M | $28.2M |
| Debt incl. finance leases | $212M | $289M | $290M | $320M | $373M |
| Net debt / EBITDA | 4.2x | 6.1x | 12.0x | 4.1x | 5.1x |
| Debt / equity | 0.5x | 0.7x | 0.7x | 0.8x | 0.9x |
| Interest coverage | 1.9x | 4.6x | 1.0x | 2.4x | 2.4x |
| Total assets | $676M | $826M | $834M | $869M | $928M |
| Total liabilities | $281M | $392M | $409M | $482M | $525M |
| Shareholders' equity | $395M | $434M | $425M | $387M | $403M |
| Net debt (β = net cash) | $172M | $269M | $259M | $252M | $345M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 4 | 5 / 7 | 5 / 7 | 5 / 7 | 5 / 7 | 4 / 7 |
| Accruals ratio | β | 2.1% | β6.3% | β4.3% | β6.6% | β9.7% | β0.4% |
| Altman Z'' | β | β | β | β | β | β | β |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $44.9M | $67.4M | $151M | $198M | $242M | $296M | $297M |
| Operating income | $12.8M | $8.7M | $40.3M | $43.4M | $20.9M | $60.6M | $65.5M |
| Interest expense | $9.4M | $10.7M | $21.4M | $9.5M | $21.9M | $25.5M | $27.3M |
| Pretax income | $1.4M | β$3.0M | $3.7M | $35.5M | β$3.1M | $28.4M | $32.4M |
| Income tax | β$10.5M | β$26.8M | β$7.1M | $6.1M | $4.6M | $8.7M | $9.4M |
| Net income | $11.9M | $23.1M | $9.2M | $29.2M | β$7.1M | $18.7M | $19.5M |
| Diluted EPS | $0.19 | $0.36 | $0.08 | $0.24 | β$0.06 | $0.16 | $0.17 |
| Diluted shares | 0.00B | 0.06B | 0.11B | 0.12B | 0.12B | 0.12B | 0.12B |
| Cash flow | |||||||
| Cash from operations | $16.8M | $10.7M | $49.0M | $61.7M | $47.7M | $101M | $23.0M |
| Capital expenditure | $0.0M | $0.0M | $0.1M | $1.3M | $1.2M | $4.4M | $4.9M |
| Free cash flow | $16.8M | $10.6M | $48.9M | $60.4M | $46.5M | $96.6M | $18.1M |
| Depreciation and amortization | $0.0M | $0.1M | $0.3M | $0.5M | $0.7M | $0.9M | $1.9M |
| Stock-based compensation | $0.4M | $0.7M | $3.5M | $18.6M | $34.7M | $30.5M | $37.1M |
| Acquisitions | β | $214M | $44.6M | $96.5M | $0.0M | $0.0M | $40.2M |
| Dividends paid | β | $0.0M | $0.0M | $10.5M | $14.8M | $15.5M | $16.3M |
| Dividends and buybacks | β | $0.0M | $0.0M | $10.5M | $14.8M | $15.5M | $16.3M |
| Balance sheet | |||||||
| Cash and short-term investments | $18.7M | $11.8M | $40.9M | $20.0M | $30.5M | $67.5M | $28.2M |
| Total debt | β | $290M | $212M | $289M | $290M | $320M | $373M |
| Property and equipment, net | β | $1.1M | $1.0M | $2.9M | $3.3M | $6.8M | $10.2M |
| Goodwill | $97.3M | $370M | $419M | $507M | $506M | $506M | $559M |
| Intangible assets | β | $144M | $129M | $152M | $123M | $97.6M | $107M |
| Total assets | β | $582M | $676M | $826M | $834M | $869M | $928M |
| Total liabilities | β | $324M | $281M | $392M | $409M | $482M | $525M |
| Shareholders' equity | $36.0M | $59.8M | $395M | $434M | $425M | $387M | $403M |
| Margins | |||||||
| Operating margin | 28.5% | 12.9% | 26.8% | 21.9% | 8.7% | 20.4% | 22.0% |
| EBITDA margin | 28.6% | 13.1% | 27.0% | 22.1% | 9.0% | 20.8% | 22.7% |
| Net margin | 26.6% | 34.3% | 6.1% | 14.7% | β3.0% | 6.3% | 6.6% |
| FCF margin | 37.4% | 15.8% | 32.5% | 30.4% | 19.2% | 32.6% | 6.1% |
| Returns | |||||||
| Return on capital | β | 2.0% | 7.1% | 5.1% | 2.4% | 6.6% | 6.2% |
| Return on equity | 33.1% | 48.2% | 4.0% | 7.0% | β1.7% | 4.6% | 4.9% |
| Return on assets | β | 4.0% | 1.5% | 3.9% | β0.9% | 2.2% | 2.2% |
| Growth | |||||||
| Revenue growth | β | 50.0% | 123.5% | 31.8% | 21.9% | 22.6% | 0.3% |
| Net income growth | β | 93.3% | β60.3% | 218.4% | β124.4% | β | 4.3% |
| EPS growth | β | 89.5% | β77.8% | 200.0% | β125.0% | β | 6.3% |
| FCF growth | β | β36.6% | 359.7% | 23.5% | β23.0% | 107.7% | β81.3% |
| Share count change | β | 102,273.8% | 73.1% | 8.3% | β4.6% | 3.7% | β1.9% |
| Financial health | |||||||
| Net debt / EBITDA | β | 31.6x | 4.2x | 6.1x | 12.0x | 4.1x | 5.1x |
| Debt / equity | β | 4.8x | 0.5x | 0.7x | 0.7x | 0.8x | 0.9x |
| Interest coverage | 1.4x | 0.8x | 1.9x | 4.6x | 1.0x | 2.4x | 2.4x |
| Capital allocation | |||||||
| Capex / revenue | 0.1% | 0.1% | 0.1% | 0.7% | 0.5% | 1.5% | 1.6% |
| Stock comp / revenue | 0.9% | 1.1% | 2.3% | 9.4% | 14.3% | 10.3% | 12.5% |
| Payouts / FCF | β | 0.0% | 0.0% | 17.4% | 31.9% | 16.0% | 90.2% |
| Quality scores | |||||||
| Piotroski F-score | β | β | 5.0 | 5.0 | 5.0 | 5.0 | 4.0 |
| Accruals ratio | β | 2.1% | β6.3% | β4.3% | β6.6% | β9.7% | β0.4% |
Source: SEC EDGAR XBRL filings (CIK 0001841968). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.